title: Fibrinolytic activity is highly influenced by long-term glycemic control in Type 1 diabetic patients.
authors.forename: I
authors.initials: I
authors.lastname: Seljeflot
authors.forename: J R
authors.initials: JR
authors.lastname: Larsen
authors.forename: K
authors.initials: K
authors.lastname: Dahl-Jørgensen
authors.forename: K F
authors.initials: KF
authors.lastname: Hanssen
authors.forename: H
authors.initials: H
authors.lastname: Arnesen
mesh_terms: D000328:Adult; D050197:Atherosclerosis / Q000097:blood / Q000209:etiology; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D005260:Female; D005342:Fibrinolysis; D006454:Hemoglobins / Q000378:metabolism*; D006801:Humans; D007249:Inflammation / Q000097:blood / Q000150:complications; D007332:Insulin Infusion Systems; D008297:Male; D008875:Middle Aged; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood; D012307:Risk Factors; D013927:Thrombosis / Q000097:blood / Q000209:etiology; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D006454:Hemoglobins; D017395:Plasminogen Activator Inhibitor 1; C051321:SERPINE1 protein, human; D014409:Tumor Necrosis Factor-alpha; C058244:acetylated hemoglobin